Context: Researchers from the Indian Institute of Technology-Guwahati (IIT-G) and the Bose Institute, Kolkata have developed an advanced injectable hydrogel for localised cancer treatment. A statement issued by the IIT-G said this hydrogel serves as a stable reservoir for anti-cancer drugs, releasing it in a controlled manner while sparing healthy cells from harm. The findings of the research, expected
to be revolutionary for breast cancer therapy. This work exemplifies how scientific innovation can address the pressing needs of cancer treatment. The hydrogel’s properties allow it to work harmoniously with the biological environment, offering precision.
Explore expert analysis, daily updates, and exam-focused resources tailored for serious aspirants like you!
Key points
· Hydrogel: The hydrogel is a three-dimensional polymer network that is water-based. It is designed to absorb and retain fluids, mimicking living tissues. This unique structure makes it suitable for various biomedical applications, particularly in drug delivery systems.
· Composition of the Hydrogel: The hydrogel is composed of ultra-short peptides, which are biocompatible and biodegradable protein building blocks. Its formulation ensures that it remains insoluble in biological fluids, allowing it to stay localised at the injection site.
·Mechanism of Action: The hydrogel is engineered to respond to elevated levels of glutathione
(GSH), a molecule commonly found in tumour cells. When the hydrogel encounters high GSH levels, it triggers a controlled release of the chemotherapy drug directly into the tumour, minimising interaction with healthy tissues and reducing systemic side effects.
·Efficacy in Preclinical Trials: In preclinical trials involving a murine model of breast cancer, the hydrogel demonstrated remarkable efficacy. A single injection containing the chemotherapy drug Doxorubicin resulted in approximately 75% reduction in tumour size within just 18 days.
·Advantages Over Traditional Treatments: This hydrogel delivery system enhances drug effectiveness while reducing the required dosage, which helps to minimise toxicity. It improves drug uptake by cancer cells, induces cell cycle arrest, and promotes programmed cell death, attacking tumours on multiple fronts.
·Future Implications of the Research: The researchers believe this hydrogel could change the landscape of cancer treatment. The ability to deliver drugs precisely to the tumour site while sparing healthy cells may lead to improved patient outcomes and fewer side effects compared to conventional therapies. The innovative approach exemplifies how scientific advancements can address critical healthcare challenges.
